Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-02 | Amended | $7,100,292 | $1,775,832 | Equity Only | 06b | SEC link |
| 2024-10-04 | New | $5,324,460 | $5,324,460 | Equity Only | 06b | SEC link |
| 2023-09-21 | New | $525,000 | $525,000 | Debt Only | 06b | SEC link |
| 2023-04-11 | New | $5,878,666 | $5,878,666 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jack Hoppin | Director |
| Christian Lackas | Director |
| William Parfet | Director |
| Matthew Silva | Director, Executive |